Karen Daily, DO - Research

Research at a glance

Top areas of exploration

Breast Neoplasms , 10 publications
Neoplasms , 3 publications
Neoplasm Recurrence, Local , 3 publications
Antineoplastic Combined Chemotherapy Protocols , 3 publications

Research activity

40 publications

458 citations

Why is this important?

Active clinical trials

MK-2870 as a Single Agent and in Combination With MK-3475 Versus TPC (MK-2870-010)

The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor鈥�

Investigator: Karen Daily
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2* early breast cancer with intermediate-high or high risk for disease recurrence who completed鈥�

Investigator: Karen Daily
Status: Accepting Candidates
Ages: 18 Years - 130 Years
Sexes: All

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cance

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications鈥�

Investigator: Karen Daily
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

40 publications

2021

Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.

Annals of surgical oncology

鈥�

2021

Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma.

The oncologist

鈥�

2021

The association between cognitive impairment and breast and colorectal cancer screening utilization.

BMC cancer

鈥�

2020

A case for Tamoxifen with ovarian function suppression.

Breast cancer research and treatment

鈥�

2020

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.

JAMA oncology

鈥�

BOB体育